Evidence map›Paper›PMID 29858265›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2018

Exacerbated

Christopher W Farnsworth, Eric M Schott, Abigail Benvie, Stephen L Kates, Edward M Schwarz, Steven R Gill, Michael J Zuscik, Robert A Mooney

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 34 citations in OpenAlex.

  1. PGEThe Journal of investigative dermatology · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Christopher W FarnsworthDepartment of Pathology and Laboratory Medicine, University of Rochester, Rochester, NY 14642.ORCID 0000-0001-7169-3850
Eric M SchottDepartment of Pathology and Laboratory Medicine, University of Rochester, Rochester, NY 14642.
Abigail BenvieDepartment of Pathology and Laboratory Medicine, University of Rochester, Rochester, NY 14642.ORCID 0000-0002-0160-1890
Stephen L KatesDepartment of Orthopaedic Surgery, Virginia Commonwealth University, Richmond, VA 23298; and.
Edward M SchwarzCenter for Musculoskeletal Research, University of Rochester, Rochester, NY 14642.ORCID 0000-0002-4854-9698
Steven R GillDepartment of Microbiology and Immunology, University of Rochester, Rochester, NY 14642.
Michael J ZuscikCenter for Musculoskeletal Research, University of Rochester, Rochester, NY 14642.
Robert A MooneyDepartment of Pathology and Laboratory Medicine, University of Rochester, Rochester, NY 14642; robert_mooney@urmc.rochester.edu.ORCID 0000-0002-6651-4747
University of Rochester · USVirginia Commonwealth University · US

Funding

The University of Rochester's Clinical and Translational Science InstituteUL1TR002001 · NCATS · UNIVERSITY OF ROCHESTER · PI WILSON, KAREN M., ZAND, MARTIN S · 2016 to 2024
$34.6M
The University of Rochester's Clinical and Translational Science InstituteUL1TR000042 · NCATS · UNIVERSITY OF ROCHESTER · PI BENNETT, NANCY M, KIEBURTZ, KARL D. · 2012 to 2015
$14.4M
Project 2: Defining the Protective vs. Susceptible Immune Proteome of S. aureus OsteomyelitisP50AR072000 · NIAMS · UNIVERSITY OF ROCHESTER · PI Benjamin L Miller · 2017 to 2026
$13.6M
Rochester Resource-Based Center for Bone, Muscle and Orthopaedic Research (ROCSTARR) (Overall Application)P30AR069655 · NIAMS · UNIVERSITY OF ROCHESTER · PI Edward M. Schwarz · 2016 to 2026
$7.8M
Training in Orthopaedic Researchhttps://apps.era.nih.gov/grantfolder/viewInternalGF.era?applId=8841318&folderId=90T32AR053459 · NIAMS · UNIVERSITY OF ROCHESTER · PI ZUSCIK, MICHAEL J · 2006 to 2017
$3.4M
NCATS NIH HHS UL1 TR000042NCATS NIH HHS UL1 TR002001NIAMS NIH HHS P30 AR069655NIAMS NIH HHS P50 AR072000NIAMS NIH HHS T32 AR053459
6 · The paper itself

Abstract

Obese patients with type 2 diabetes (T2D) are at an increased risk of foot infection, with impaired immune function believed to be a critical factor in the infectious process. In this study, we test the hypothesis that humoral immune defects contribute to exacerbated foot infection in a murine model of obesity/T2D. C57BL/6J mice were rendered obese and T2D by a high-fat diet for 3 mo and were compared with controls receiving a low-fat diet. Following injection of

Indexed as

AICDA (Activation-Induced Cytidine Deaminase)AnimalsB-LymphocytesCell DifferentiationCells, CulturedCytidine DeaminaseDiabetes Mellitus, Type 2Diet, High-FatDisease Models, AnimalDisease ProgressionFootGerminal CenterHumansImmunity, HumoralImmunoglobulin Class SwitchingMaleAICDA (Activation-Induced Cytidine Deaminase)Cytidine Deaminase

Identifiers

PMID29858265
PMCPMC6039240
OpenAlexW2806633351

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.